A peptide-based photoaffinity label for the catalytic subunit of the cAMP-dependent protein kinase was prepared from the amino acid p-benzoyl-L-phenylalanine [L-Phe(pBz)]. By using solid-phase peptide synthesis methodology, DL-Phe(pBz) was incorporated into the cAMP-dependent protein kinase substrate Leu-Arg-Arg-Ala-Ser-Leu-Gly in place of the phosphorylatable serine. The diastereomeric peptides were separated by reverse-phase HPLC. The peptide substrate analog containing L-Phe(pBz) had a Ki of approximately 110 IAM at pH 7.5. When photolyzed at 350 nm in the presence of the enzyme, this peptide caused time-and concentration-dependent inactivation. Radioactive acetylated L-Phe-(pBz) peptide was used to establish the binding stoichiometry of peptide to enzyme; these results, together with protection experiments, showed the photoaffinity labeling to be specific (~1:1). To identify the residues that were modified on the catalytic subunit, the photoinactivated enzyme was cleaved with CNBr and V8 protease (Staphylococcus aureus). The resulting peptide fragments were purified by HPLC and were sequenced; these experiments identified the modified residues as Gly-125 and Met-127. This region of the cAMP-dependent protein kinase catalytic subunit contains many residues that are conserved in serine-and tyrosine-protein kinases.
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The cAMP-dependent protein kinase is a central enzyme in eukaryotic metabolism and is believed to be responsible for all of the physiological effects of cAMP (1) . The inactive holoenzyme contains two regulatory and two catalytic subunits. Upon binding of cAMP, the holoenzyme dissociates to give two catalytic subunits and a regulatory dimer (2) . The catalytic subunit catalyzes the transfer of the y-phosphoryl group of ATP to appropriate protein or peptide substrates.
The primary sequence of the catalytic subunit has been determined (3), but the structure of the enzyme active site remains unclear. The conformation of a peptide substrate bound to the enzyme has been deduced from NMR measurements (4, 5) . Several investigators have used affinity labels to study the regulatory and catalytic subunits of the enzyme. The catalytic subunits from bovine heart (6) and porcine skeletal muscle (7) have been modified with the reagent 5'-(p-fluorosulfonylbenzoyl)adenosine; this label was shown to modify Lys-72 specifically (8) . Bramson et al. (9) modified Cys-199 with the peptide Leu-Arg-Arg-Ala-Cys(3-nitro-2-pyridinesulfenyl)-Leu-Gly and concluded that this residue was in the enzyme active site. This experiment demonstrated the feasibility of using analogs of kemptide (Leu-Arg-ArgAla-Ser-Leu-Gly), a good substrate of the enzyme (10) , to modify the peptide binding site. Peptides containing N8-bromoacetylornithine have been used to alkylate ; M. Doughty and E.T.K., unpublished results). This paper describes the synthesis of a photoaffinity label designed to modify the peptide binding site of the catalytic subunit. The amino acid p-benzoyl-L-phenylalanine [LPhe(pBz)] was chosen as the photoactive probe because of(i) the stability of benzophenones to peptide synthesis conditions, (ii) the high reactivity of the a,,B-unsaturated ketones in the presence of light with wavelength >300 nm (12) , and (iii) the low reactivity of these species to water (13) . The development of this photoactive amino acid has been reported in a preliminary communication by us (14) and by other investigators (15 Amino acid analyses were carried out on a Dionex D300 amino acid analyzer after hydrolysis of the peptide in 6 N constant-boiling HCO (Pierce) at 110°C for 24 hr. The catalytic subunit of the cAMP-dependent protein kinase was purified from bovine heart (9).
Synthesis of DL-Phe(pBz). p-Aminobenzophenone (0.03 mol) was dissolved in acetone (300 ml). The solution was cooled to 4°C in an ice bath, and concentrated HBr (16 ml of 48%) was added with stirring. The amine was diazotized with 60 ml of 5 M sodium nitrite. Acrylic acid (100 ml) and CuBr (300 mg) were added immediately, and the reaction mixture was allowed to warm to 25°C. After 90 min, N2 evolution ceased, and the reaction was concentrated in vacuo to remove acetone and most of the acrylic acid and water. The residue was dissolved in 0.5 M NaHCO3 (200 ml) and was washed twice with chloroform. The aqueous layer was acidified with concentrated HBr and washed several times with ether.
The a-bromohydrocinnamic acid was precipitated as the dicyclohexylamine salt by addition of one equivalent of dicyclohexylamine to the combined ether extracts. Crystals [mp 192-194°C (16) . This was utilized to incorporate DL-Phe(pBz) into the peptide sequence Leu-Arg-Arg-Ala-DL-Phe(pBz)-Leu-Gly by stepwise solid-phase synthesis on Merrifield resin. The Merrifield resin ester of N-protected glycine was prepared as described by Horiki et al. (17) . The Boc-protected amino acids were coupled as symmetric anhydrides (18), except for BOC-DLPhe(pBz), which was incorporated by using hydroxybenzotriazole/dicyclohexylcarbodiimide coupling (19) . The fully protected peptides were cleaved from the resin and simultaneously deprotected by treatment with HF (20) .
Peptide Purification. The peptides were extracted from the resin with 10% acetic acid and loaded on a 1. The amino acid compositions of the peptides were confirmed by amino acid analysis, 360-MHz NMR, and fission fragment ionization mass spectroscopy. The diastereomers were identified by digestion with leucine aminopeptidase (Worthington). Enzyme and peptide (1:100) were incubated at 37°C in 0.2 M triethylammonium acetate (pH 8.3) for 4 hr. These enzymatic digests were analyzed by HPLC as described in Results. Amino Enzyme Assays. The catalytic subunit of cAMP-dependent protein kinase was assayed according to the method of Bramson et al. (21) . This method takes advantage of the spectral change at 430 nm due to the phosphorylation of Leu-Arg-Arg-Tyr(o-nitro)-Ser-Leu-Gly catalyzed by the catalytic subunit. These assays were typically done at pH 7.5 and contained 50 Determination of Binding Stoichiometry. Irradiated enzyme-substrate complexes (in approximately 250-plI aliquots) were precipitated as follows: 100 ,ul of bovine serum albumin at 10 mg/ml was added with 500 1.l of the Mops buffer. The protein in this solution was precipitated by addition of 100 1.l of 70% HCl04. The precipitate was collected on a Millipore HA filter, washed extensively with 7% HCJ04, resuspended in water, and assayed in Hydrofluor in a Beckman LS/7000 liquid scintillation counter.
Identification of the Modified Site. A 1.0-mM solution of [3H]acetyl-peptide 1 (specific activity of 100,000 dpm/nmol) in 50 mM Mops/150 mM KCI, pH 7.0, was mixed with 2 mg of catalytic subunit (in 1 ml of Mops buffer) and irradiated for 20 min at 350 nm. Less than 10% enzyme activity remained after this treatment. The mixture was filtered through a Centricon-30 (Mr cutoff of 30,000) (Amicon) driven by centrifugation at 4640 x g. The retentate was washed several times with Mops buffer to remove excess peptide. The modified protein was dissolved in 2.5 ml of 70% (vol/vol) formic acid and was treated with a 50-fold excess of CNBr (22) . This reaction proceeded for 24 hr at room temperature.
The resultant solution was passed through a Centricon-30 to remove unreacted enzyme. The filtrate was then passed through a Centricon-10 (Mr cutoff of 10,000), and the retentate was washed repeatedly with water. The Centricon-10 filtrate contained =60% of the initial radioactivity, and the retentate contained the remainder. The Centricon-10 retentate was concentrated and dissolved in 50 mM NH4HCO3 (pH 7.8) and was incubated with 3.3 nmol (one-sixth equivalent) of V8 protease from Staphylococcus aureus (Cooper Biomedical, Malvern, PA). This reaction was allowed to proceed for 24 hr at 370C. Afterwards, the reaction mixture was filtered through a Centricon-10 and washed several times with H20; the filtrate contained all of the radioactivity that had been present in the retentate.
Both of the Centricon-10 filtrate fractions were then analyzed by HPLC by using a Vydac C18 column (4.6 mm x 25 cm) (The Separations Group, Hesperia, CA). A 60-min gradient of 0-50o CH3CN was employed in a solution containing 200 mM NaCl04 and 25 mM NaH2PO4 (pH 2.5).
Fractions corresponding to peaks of absorbance at 220 nm were collected, and an aliquot of each was counted in Hydrofluor. Fractions containing radioactivity were concentrated in vacuo and rechromatographed on the same column using a 60-min gradient of 0-50% CH3CN in 0.1% trifluoroacetic acid. Active fractions from the second round of HPLC were concentrated in vacuo and subjected to the Edman degradation on an Applied Biosystems (Foster City, CA) gas-phase sequenator. The quantities of peptide sequenced in this way were 1-2 nmol per fragment. IBM HPLC with a NaCIO4/NaH2PO4/CH3CN solvent system. The amino acid compositions of the peptides were confirmed by amino acid analysis, 360-MHz NMR, and fission fragment ionization mass spectrometry. The diastereomers were identified by digestion with leucine aminopeptidase (4 hr at 370C). The digests were injected onto the same HPLC system described above and monitored at 262 nm. The digest of the first diastereomeric peptide yielded a new peak Proc. Natl. Acad. Sci. USA Phe(pBz) . The digest of the second peptide yielded no peak at this position. Because leucine aminopeptidase is highly specific for L-amino acids (24) , these results identify the first peptide as peptide 1 [containing L-Phe(pBz)].
RESULTS
Photolysis of Peptide 1. Fig. 1 shows the effect of the length of time of irradiation on the absorption spectrum of peptide 1. The absorption at 262 nm decreases as a function of duration of photolysis, and the rate of photolysis follows apparent first-order kinetics (Fig. 1 Inset) . The half-time is -70 sec under these conditions (50 mM Mops, pH 7.5). Incubation of peptide 1 with 400 ,uM Ser, 400 ,uM Cys, or 400 ,4M Ala had no effect on the photolysis. The products of photolysis under the nonenzymatic conditions have not been identified.
Reversible Binding of Peptides 1 and 2 by the Catalytic Subunit of cAMP-Dependent Protein Kinase. Peptides 1 and 2 were tested as competitive inhibitors of the catalytic subunit of the cAMP-dependent protein kinase. The spectrophotometric assay was used, as described in Materials and Methods. The enzyme concentration in the assays was 12.3 nM. Lineweaver-Burk plots were constructed, and the data were replotted as described by Dixon (25) . From these plots the Ki values for peptides 1 and 2 were estimated to be 110 ± 15 /LM and 650 ± 50 /LM, respectively.
Photoinactivation of the Catalytic Subunit by Photoaffinity Substrate Analogues. Catalytic subunit (100 nM) was incubated with various concentrations of peptide 1 in 50 mM Mops (pH 7.5) and photolyzed for up to 10 min. Aliquots were withdrawn and assayed for phosphotransferase activity by using the spectrophotometric assay described above. The enzyme was photoinactivated in a time-and concentrationdependent manner, as shown in Fig. 2 The experiments were performed in 50 mM Mops (pH 7.5) at 25°C. The concentration of catalytic subunit was 100 nM. One hundred percent activity was taken to be the activity of the enzyme/peptide mixture before photolysis. Catalytic subunit was assayed by a spectrophotometric method (21) .
the enzyme retained activity after photolysis in the presence of prephotolyzed peptide 1 1 (2000 dpm/nmol) was used to determine the stoichiometry of binding of peptide to enzyme. The photolysis was carried out as before, with various concentrations of peptide and enzyme. Aliquots were removed at various time points and assayed for enzyme activity. Extra aliquots were also removed at these time points to assess the extent of label incorporation into the catalytic subunit. These results showed that the protein modification was covalent and that the stoichiometry was -1:1 (Fig. 3) .
In a separate experiment, the catalytic subunit (2 mg) was irradiated together with [3H]acetyl-peptide 1 (100,000 dpm/ nmol) until >90% loss of activity resulted. The excess photoaffinity label was removed by filtration over a Centricon-30. The modified enzyme was then cleaved with CNBr and filtered successively over a Centricon-30 and a Centricon-10. Approximately 60% of the radioactivity flowed through the latter membrane, indicating that the label was present in peptide fragments from the CNBr cleavage reaction that were of a M. <10,000. The fraction containing the remaining 40% of the radioactivity was recovered and digested with S. aureus V8 protease and filtered through a Centricon-10.
Biochemistry: Miller Both batches of Centricon-10 filtrate were then analyzed by analytical HPLC using a reverse-phase C18 column. The radioactive fragments were purified initially using a linear gradient of CH3CN and an aqueous solution containing NaClO4 and NaH2PO4. The major peak of radioactivity from the small peptide produced by cleavage with CNBr eluted at 46 min (Fig. 4B) . Major peaks of radioactivity from the V8 protease digest of the large fragment from CNBr cleavage eluted at 36 and 45 min (Fig. 4C) . For both samples, fractions were collected, concentrated, and further purified by rechromatography by C18 HPLC using 0.1% trifluoroacetic acid. The elution times of the small CNBr fragment and the major product from the V8 protease digest of the large CNBr fragment were 45 and 34 min, respectively, in the trifluoroacetic acid buffer system. The radioactive fractions from the second round of HPLC were applied to a gas-phase sequenator and carried through the Edman degradation. The fragments obtained and the sites of modification are shown in Table 1 . The two residues modified were Gly-125 and Met-127. These residues are contained in the CNBr peptide beginning at Met-119 and ending at Met-127; however, modification of the latter residue apparently blocked CNBr cleavage at that site, generating the large CNBr fragment. As a reference, native, unmodified catalytic subunit (1 mg) was carried through the CNBr cleavage, HPLC analysis, and sequencing. The unmodified CNBr peptide from Met-119 to Met-127 eluted at 38 min in the initial gradient (Fig. 4A) .
DISCUSSION
High-resolution structural data are not available for any of the protein kinases, although a preliminary study of crystals of the cAMP-dependent protein kinase has been reported (29) . Extensive amino acid homology exists among the catalytic domains of the serine-and tyrosine-protein kinases (26) . To begin to identify residues and domains important in binding and catalysis, we have chosen as our model system the catalytic subunit of the bovine heart cAMP-dependent protein kinase. This enzyme is readily purified in milligram quantities, and a synthetic peptide substrate (kemptide) is available, which is phosphorylated with favorable kinetic parameters (10) . The conformation of this peptide bound to the active site of cAMP-dependent protein kinase has been elucidated (4, 5) .
We report here the extension of our peptide-based affinity labeling studies to photoaffinity labeling. Because peptides in which the reactive serine of kemptide is replaced by 3-nitro-2-pyridinesulfenyl-cysteine also bind to the catalytic subunit (9), this site was chosen for the introduction ofthe photolabile amino acid L-Phe(pBz). Peptide 1 was synthesized and found to have a Ki of 110 ,uM when tested as a competitive inhibitor of the catalytic subunit. It was also a potent photoinactivator (Fig. 2) ; it left the enzyme -90% inactive after 1 min of photolysis at 250C in 50 mM Mops (pH 7.5) .
A potential problem with photoaffinity labeling experiments is the possibility of nonspecific interactions on the enzyme or receptor surface (27) . To address this question, the catalytic subunit was photolyzed in the presence of (i) Phe(pBz) itself, and (ii) peptide 2, the analog of kemptide containing D-Phe(pBz) in place of serine. No photoinactivation was observed in either case, indicating that tight binding at the active site is required for the effect. To strengthen this argument, protection experiments were carried out in which other active site-directed reagents protected the photoinactivation of the enzyme by peptide 1. Finally, radiolabeled peptide 1 was used to establish a linear relationship between photoinactivation and covalent attachment (Fig. 3) . This experiment demonstrates that at 100% inactivation 1 mol of photoaffinity label would be incorporated per mol of enzyme.
To identify the residues modified, the catalytic subunit was photolyzed together with [3H]acetyl-peptide 1 and was subsequently cleaved with CNBr and V8 protease. To separate different sized fragments quickly, Mr 10,000 and Mr 30,000 cutoff Centricon devices were used with centrifugation at 4640 x g, as reported previously (11) . By this analysis ==60% of the radioactivity was shown to be associated with a small (Mr < 10,000) CNBr peptide. This peptide was purified by two rounds of HPLC puritication and subjected to N-terminal Edman degradation on a gas-phase sequenator. The sequence obtained corresponds to the amino acids between positions 120 and 124 of the catalytic subunit and did not include (Table 1 ). Since no proteolytic cleavage was expected between Gly-125 and Glu-126, these results indicate the site of attachment to be Gly-125.
The larger (Mr > 10,000) CNBr fragments that contained 40% of the original radioactivity were digested with V8 protease and were analyzed by the same methodology. In this case, the sequence corresponded to residues 121-126 of the enzyme, with sequence termination and observation of an unknown phenylthiohydantoin at the next round of sequencing. These results indicate modification at residue Met-127; this modification apparently blocks both the CNBr reaction at that position and V8 protease cleavage at Glu-126.
Alignment of the amino acid sequences in catalytic domains of serine-and tyrosine-protein kinases shows that a high degree of homology exists among these enzymes (26) . When the sequences are arranged as described by Hunter and Cooper (26) , the portion of the cAMP-dependent protein kinase modified by peptide 1 falls in a region that has homology with other protein kinases, with Gly-125 being a conserved residue (Table 2 ). In addition, the length of the peptide chain between Gly-125 and Lys-72, a residue important in ATP binding in the cAMP-dependent protein kinase (8) , is approximately conserved in other serine-and tyrosine-protein kinases. Taken together, this argues that this protein of the active site in the cAMP-dependent protein kinase contains structural features that may be preserved in other protein kinases. The photochemistry of diaryl ketones is well understood from model systems (12, 28) . Upon irradiation at 350 nm, the ketone carbonyl of Phe(pBz) is expected to undergo a n,I* transition to give a triplet biradical. This species has been shown to react preferentially with C-H bonds as compared to water (13) . The resulting tertiary alcohol is a stable adduct. In the present study, a glycine and a methionine residue have been modified. In the case of glycine, the target for the photochemical reaction is presumably the a-carbon of glycine. The nature of the adduct with methionine has not been elucidated. Photoaffinity labels containing L-Phe(pBz) should be complementary to other types of affinity labels, as the photogenerated free radicals are anticipated to modify covalently non-nucleophilic sites on proteins.
